Biod Products Estimated To Be $ 10 Billion In Value. Read
Scott Matusow Seeking Alpha Can Google It.
Biodel (BIOD) is expecting top-line Phase II data for BIOD-123 to be released in the third quarter 2013. Withthe market for these products estimated to be about $10 billion in value, good results for Biodel's product would be a major step for the company and serve as a top-notch catalyst for biotech investors.
I like BIOD here, but 10B? Nah, I read Humalog is worth like 3B. Accumulate with caution. Too much pump in this stock which makes me nervous. Also, no insider buying which is a big deal on BIO stocks. Look at ANAC today on the insider buying news..just sating